68 related articles for article (PubMed ID: 10472360)
21. p53 codon 72 polymorphism in cervical cancer patients and healthy women from Poland.
Dybikowska A; Dettlaff A; Konopa K; Podhajska A
Acta Biochim Pol; 2000; 47(4):1179-82. PubMed ID: 11996107
[TBL] [Abstract][Full Text] [Related]
22. p53 codon 72 polymorphism and risk of cervical cancer in UK.
Rosenthal AN; Ryan A; Al-Jehani RM; Storey A; Harwood CA; Jacobs IJ
Lancet; 1998 Sep; 352(9131):871-2. PubMed ID: 9742979
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism at codon 72 of p53 is not associated with cervical cancer risk.
Malcolm EK; Baber GB; Boyd JC; Stoler MH
Mod Pathol; 2000 Apr; 13(4):373-8. PubMed ID: 10786802
[TBL] [Abstract][Full Text] [Related]
24. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
[TBL] [Abstract][Full Text] [Related]
25. [Human papillomavirus infection and other risk factors for cervical cancer in Chinese and Australian patients].
Liu JH; Huang X; Liao GW; Li JD; Li YF; Li MD; Rose B; Thompson C
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):748-52. PubMed ID: 12899750
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus and p53 polymorphism in codon 72 in head and neck squamous cell carcinoma.
Hoffmann M; Scheunemann D; Fazel A; Görögh T; Kahn T; Gottschlich S
Oncol Rep; 2009 Mar; 21(3):809-14. PubMed ID: 19212643
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus infection and P53 codon 72 genotypes in a Hispanic population at high-risk for cervical cancer.
Haws AL; Woeber S; Gomez M; Garza N; Gomez Y; Rady P; He Q; Zhang L; Grady JJ; McCormick JB; Fisher-Hoch SP; Tyring SK
J Med Virol; 2005 Oct; 77(2):265-72. PubMed ID: 16121365
[TBL] [Abstract][Full Text] [Related]
28. p53 polymorphism at codon 72 is not a risk factor for cervical carcinogenesis in central Italy.
Cenci M; French D; Pisani T; Alderisio M; Lombardi AM; Marchese R; Colelli F; Vecchione A
Anticancer Res; 2003; 23(2B):1385-7. PubMed ID: 12820398
[TBL] [Abstract][Full Text] [Related]
29. p53 at codon 72 polymorphism, human papillomavirus infection and cervical lesions: a cross-sectional study from northeastern Italy.
Comar M; Molin GD; Guaschino S; Campello C
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):210-4. PubMed ID: 15140517
[TBL] [Abstract][Full Text] [Related]
30. Contribution of epigenetic risk factors but not p53 codon 72 polymorphism to the development of cervical cancer in Northeastern Thailand.
Settheetham-Ishida W; Singto Y; Yuenyao P; Tassaneeyakul W; Kanjanavirojkul N; Ishida T
Cancer Lett; 2004 Jul; 210(2):205-11. PubMed ID: 15183536
[TBL] [Abstract][Full Text] [Related]
31. The prevalence of the HPV 16 genome, integrated viral status and p53 genotype in cervical cancer population of north-eastern Hungary, the correlation with the established markers of tumour progression.
Hernádi Z; Sápy T; Krasznai ZT
Eur J Obstet Gynecol Reprod Biol; 2004 Mar; 113(1):83-6. PubMed ID: 15036717
[TBL] [Abstract][Full Text] [Related]
32. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India.
Saranath D; Khan Z; Tandle AT; Dedhia P; Sharma B; Contractor R; Shrivastava S; Dinshaw K
Gynecol Oncol; 2002 Aug; 86(2):157-62. PubMed ID: 12144822
[TBL] [Abstract][Full Text] [Related]
33. Association of specific genotype and haplotype of p53 gene with cervical cancer in India.
Mitra S; Misra C; Singh RK; Panda CK; Roychoudhury S
J Clin Pathol; 2005 Jan; 58(1):26-31. PubMed ID: 15623478
[TBL] [Abstract][Full Text] [Related]
34. The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women.
Assoumou SZ; Boumba AL; Ndjoyi-Mbiguino A; Khattabi A; Ennaji MM
Med Oncol; 2015 Jan; 32(1):281. PubMed ID: 25502079
[TBL] [Abstract][Full Text] [Related]
35. [Study on the relationship between cervical cancer and p53 codon 72 polymorphism].
Qie M; Zhang Y; Wu J
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):274-5. PubMed ID: 12575207
[TBL] [Abstract][Full Text] [Related]
36. Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women.
Kim JW; Roh JW; Park NH; Song YS; Kang SB; Lee HP
Am J Obstet Gynecol; 2001 Jan; 184(2):55-8. PubMed ID: 11174479
[TBL] [Abstract][Full Text] [Related]
37. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women.
Arbel-Alon S; Menczer J; Feldman N; Glezerman M; Yeremin L; Friedman E
Int J Gynecol Cancer; 2002; 12(6):741-4. PubMed ID: 12445252
[TBL] [Abstract][Full Text] [Related]
38. The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer.
Pegoraro R; Moodley J; Naiker S; Lanning P; Rom L
BJOG; 2000 Sep; 107(9):1164-5. PubMed ID: 11002963
[TBL] [Abstract][Full Text] [Related]
39. Homozygous arginine at codon 72 of p53 has no prognostic significance in cervical cancer.
Ngan HY; Liu VW; Liu SS; Cheng DK; Ng TY; Wong LC
Tumour Biol; 2000; 21(3):135-8. PubMed ID: 10754463
[TBL] [Abstract][Full Text] [Related]
40. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.
El khair MM; Ennaji MM; El kebbaj R; Mhand RA; Attaleb M; El Mzibri M
Med Oncol; 2010 Sep; 27(3):861-6. PubMed ID: 19771536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
